Global Tetanus Market Research Report 2022

Tetanus antitoxin used for the prevention and treatment of tetanus.When tetanus or its suspicious symptoms appear, antitoxin therapy should be used in a timely manner in conjunction with surgical treatment and other therapies.When open wounds (especially deep wounds and severe pollution) are at risk of tetanus infection, timely preventive measures should be taken.Those who have been immunized against tetanus toxoid should be given another shot of toxoid to strengthen immunity after injury.Antitoxin prophylaxis should be administered to those who have not been immunized against toxoid or who have not had a clear history of immunity.
Due to the COVID-19 pandemic, the global Tetanus market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Tetanus market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Tetanus landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Monovalent Tetanus Toxoid (TT) accounting for % of the Tetanus global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Tetanus include GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur, AstraZeneca, Bharat Biotech, Roche, Novartis and MSD, etc. In terms of revenue, the global 3 largest players have a % market share of Tetanus in 2021.
This report focuses on Tetanus volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Tetanus market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Tetanus Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Monovalent Tetanus Toxoid (TT)
Diphtheria
Pertussis (DTaP)
Diphtheria and Tetanus (DT)
Segment by Application
Hospitals
Clinics
Government
Research Organizations
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
GlaxoSmithKline
Merck
Pfizer
Sanofi Pasteur
AstraZeneca
Bharat Biotech
Roche
Novartis
MSD
Shenzhen Kangtai Biological Products
Bausch Health
Emergent Biosolutions
Astellas Pharma
Panacea Biotec
Shanghai Fuhong Hanlin Biopharmaceutical
Suzhou Shengdia Biomedical Co. LTD
Baitai Biological Pharmaceutical Co. LTD